HomeNewscoronavirusCoronavirus vaccine | People with comorbidities can use Co-WIN mobile app to register for vaccine

Coronavirus vaccine | People with comorbidities can use Co-WIN mobile app to register for vaccine

The Centre has developed a free mobile application that will aid in tracking and monitoring the entire vaccination drive. The new app - Co-WIN – will additionally help people with comorbidities register themselves and get coronavirus vaccine shots on priority.

December 08, 2020 / 21:15 IST
Story continues below Advertisement
Three pharma companies have applied for emergency use authorisation of their COVID-19 vaccines in India
Three pharma companies have applied for emergency use authorisation of their COVID-19 vaccines in India

Three pharma companies have applied for emergency use authorisation of their COVID-19 vaccines in India - Pfizer, Serum Institute of India (SII), and Bharat Biotech - and India’s COVID-19 vaccination drive is expected to begin soon too.

In light of the developments, the Union Health Ministry, on December 8, revealed the details of India’s vaccination programme and preparedness to conduct the massive drive. For live updates on coronavirus, click here

Addressing the media, Health Secretary Rajesh Bhushan said the Centre has developed a free mobile application that will aid in tracking and monitoring the entire vaccination drive. The new app - Co-WIN – will additionally help people with comorbidities register themselves and get coronavirus vaccine shots on priority.

Story continues below Advertisement

In the first two phases of the vaccination programme, the government will focus on vaccinating priority groups, and the Centre is currently compiling data on these two priority groups. In the first stage, frontline workers, i.e., all healthcare professionals will get the vaccine and in the second stage, emergency workers will get the COVID-19 vaccine shots.

From the third stage onwards, people with co-morbidities will be able to self-register themselves through the Co-WIN app.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show